South Africa: Lenacapavir Gains Ground As Western Cape Uptake Passes 3,600

What the report says

Daily Maverick, via Spotlight, reports that uptake of lenacapavir, a newer HIV prevention injection, is rising in South Africa’s Western Cape. The story describes the rollout at government clinics and includes the experience of a young woman in Cape Town’s Philippi area who moved from a two-monthly prevention shot to the six-monthly lenacapavir regimen. The reporting highlights how clinics are counselling patients through concerns about side effects, needles, and the adjustment to a new prevention option.

According to the national Department of Health spokesperson cited in the piece, there had been 3,641 lenacapavir initiations in the Western Cape as of 23 August, across 22 government clinics offering the injection. The national total was reported at 47,934. The article says supply remains tightly constrained, which suggests the rollout is still limited even as demand grows.

The development matters because lenacapavir offers a longer-acting HIV prevention choice at a time when young women remain a key focus of prevention efforts. More broadly, long-acting injectable prevention is becoming an important part of HIV strategy in South Africa, especially where adherence to daily or frequent medication can be difficult. The article frames the Western Cape figures as a sign that health services and public campaigns are helping more people access newer prevention tools.